These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38195090)

  • 1. Detecting thyrotropin receptor mRNA from peripheral blood of patients with differentiated thyroid cancer rules out non-aggressive cases.
    Janković Miljuš JR; Prosenc Zmrzljak U; Košir R; Jovanović M; Đorić IĐ; Rončević JV; Išić Denčić TM; Šelemetjev SA
    Ann Clin Biochem; 2024 Sep; 61(5):338-346. PubMed ID: 38195090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid-stimulating hormone receptor messenger ribonucleic acid measurement in blood as a marker for circulating thyroid cancer cells and its role in the preoperative diagnosis of thyroid cancer.
    Chia SY; Milas M; Reddy SK; Siperstein A; Skugor M; Brainard J; Gupta MK
    J Clin Endocrinol Metab; 2007 Feb; 92(2):468-75. PubMed ID: 17118994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utility of peripheral thyrotropin mRNA in the diagnosis of follicular neoplasms and surveillance of thyroid cancers.
    Milas M; Mazzaglia P; Chia SY; Skugor M; Berber E; Reddy S; Gupta M; Siperstein A
    Surgery; 2007 Feb; 141(2):137-46; discussion 146. PubMed ID: 17263967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyrotropin receptor/thyroglobulin messenger ribonucleic acid in peripheral blood and fine-needle aspiration cytology: diagnostic synergy for detecting thyroid cancer.
    Wagner K; Arciaga R; Siperstein A; Milas M; Warshawsky I; Sethu S; Reddy K; Gupta MK
    J Clin Endocrinol Metab; 2005 Apr; 90(4):1921-4. PubMed ID: 15687333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation status of TSHr in well-differentiated thyroid cancer by using cytologic material.
    Kartal K; Onder S; Kosemehmetoglu K; Kilickap S; Tezel YG; Kaynaroglu V
    BMC Cancer; 2015 Oct; 15():824. PubMed ID: 26519197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The utility of peripheral thyrotropin receptor mRNA in the management of differentiated thyroid cancer.
    Aliyev A; Soundararajan S; Bucak E; Gupta M; Hatipoglu B; Nasr C; Siperstein A; Berber E
    Surgery; 2015 Oct; 158(4):1089-93; discussion 1093-4. PubMed ID: 26212344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of circulating thyroid cancer cells in patients with thyroid microcarcinomas.
    Novosel T; Ritter HE; Gupta M; Harvey A; Mitchell J; Berber E; Siperstein A; Milas M
    Surgery; 2009 Dec; 146(6):1081-9. PubMed ID: 19958935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of benign thyroid nodules from malignant thyroid nodules through miR-205-5p and thyroid-stimulating hormone receptor mRNA.
    Zhou J; Cao L; Chen Z
    Hormones (Athens); 2021 Sep; 20(3):571-580. PubMed ID: 33788150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CIRCULATING THYROID-STIMULATING HORMONE RECEPTOR MESSENGER RNA AS A MARKER OF TUMOR AGGRESSIVENESS IN PATIENTS WITH PAPILLARY THYROID MICROCARCINOMA.
    Aliyev A; Gupta M; Nasr C; Hatipoglu B; Milas M; Siperstein A; Berber E
    Endocr Pract; 2015 Jul; 21(7):777-81. PubMed ID: 25786552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of peripheral thyrotropin receptor mRNA in follow-up of differentiated thyroid cancer.
    Milas M; Barbosa GF; Mitchell J; Berber E; Siperstein A; Gupta M
    Ann Surg Oncol; 2009 Feb; 16(2):473-80. PubMed ID: 19015922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic accuracy of circulating thyrotropin receptor messenger RNA combined with neck ultrasonography in patients with Bethesda III-V thyroid cytology.
    Aliyev A; Patel J; Brainard J; Gupta M; Nasr C; Hatipoglu B; Siperstein A; Berber E
    Surgery; 2016 Jan; 159(1):113-7. PubMed ID: 26454673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of thyrotropin-receptor messenger ribonucleic acid (mRNA) and thyroglobulin mRNA transcripts in peripheral blood of patients with thyroid disease: sensitive and specific markers for thyroid cancer.
    Chinnappa P; Taguba L; Arciaga R; Faiman C; Siperstein A; Mehta AE; Reddy SK; Nasr C; Gupta MK
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3705-9. PubMed ID: 15292293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating thyrotropin receptor mRNA as a novel marker of thyroid cancer: clinical applications learned from 1758 samples.
    Milas M; Shin J; Gupta M; Novosel T; Nasr C; Brainard J; Mitchell J; Berber E; Siperstein A
    Ann Surg; 2010 Oct; 252(4):643-51. PubMed ID: 20881771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IS MEASUREMENT OF CIRCULATING TUMOR DNA OF DIAGNOSTIC USE IN PATIENTS WITH THYROID NODULES?
    Lupo M; Guttler R; Geck Z; Tonozzi TR; Kammesheidt A; Braunstein GD
    Endocr Pract; 2018 May; 24(5):453-459. PubMed ID: 29498908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating thyroid cancer markers.
    Gupta M; Chia SY
    Curr Opin Endocrinol Diabetes Obes; 2007 Oct; 14(5):383-8. PubMed ID: 17940468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analytic and clinical validity of thyroid nodule mutational profiling using droplet digital polymerase chain reaction.
    Biron VL; Matkin A; Kostiuk M; Williams J; Cote DW; Harris J; Seikaly H; O'Connell DA
    J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):60. PubMed ID: 30249281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer risk and clinicopathological characteristics of thyroid nodules harboring thyroid-stimulating hormone receptor gene mutations.
    Mon SY; Riedlinger G; Abbott CE; Seethala R; Ohori NP; Nikiforova MN; Nikiforov YE; Hodak SP
    Diagn Cytopathol; 2018 May; 46(5):369-377. PubMed ID: 29516685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitation of thyroid-stimulating hormone receptor mRNA with real-time PCR for early diagnosis of papillary thyroid microcarcinoma.
    Qiu J; Zhang Y; Guo X; Zeng F; Zhao C; Qiu X; Wu X
    Neoplasma; 2010; 57(4):360-4. PubMed ID: 20429628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of ultrasonographic/clinical profile, cytology, and BRAF V600E mutation evaluation in thyroid nodule screening for malignancy: a prospective study.
    Rossi M; Buratto M; Bruni S; Filieri C; Tagliati F; Trasforini G; Rossi R; Beccati MD; Degli Uberti EC; Zatelli MC
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2354-61. PubMed ID: 22535974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Testing for miRNA, mRNA, and DNA on Fine-Needle Aspiration Improves the Preoperative Diagnosis of Thyroid Nodules With Indeterminate Cytology.
    Labourier E; Shifrin A; Busseniers AE; Lupo MA; Manganelli ML; Andruss B; Wylie D; Beaudenon-Huibregtse S
    J Clin Endocrinol Metab; 2015 Jul; 100(7):2743-50. PubMed ID: 25965083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.